Evaluation of biochemical markers in breast cancer.
作者信息
Coombes R C, Powles T J, Neville A M
出版信息
Proc R Soc Med. 1977 Dec;70(12):843-5. doi: 10.1177/003591577707001205.
Abstract
摘要
相似文献
1
Evaluation of biochemical markers in breast cancer.乳腺癌中生化标志物的评估。
Proc R Soc Med. 1977 Dec;70(12):843-5. doi: 10.1177/003591577707001205.
2
[Ferritin, CEA and TPA as tumor markers in breast neoplasms].[铁蛋白、癌胚抗原和组织多肽抗原作为乳腺肿瘤的肿瘤标志物]
Minerva Med. 1985 Sep 15;76(34-35):1533-4.
3
Biochemical markers in breast carcinoma.乳腺癌中的生化标志物。
Ir Med J. 1978 Sep 15;71(12):408-13.
4
[Human breast cancer markers].
Eksp Onkol. 1985;7(4):3-8.
5
Biochemical detection of recurrent breast cancer.
Cancer Detect Prev. 1988;11(3-6):303-9.
6
Evaluation of carcinoembryonic antigen test in human mammary carcinoma.
Indian J Pathol Microbiol. 1987 Oct;30(4):407-12.
7
[The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].[肿瘤标志物癌胚抗原、组织多肽抗原、糖类抗原19-9以及铁蛋白和骨钙素在乳腺癌随访研究中的应用]
Wien Klin Wochenschr. 1985 Dec 6;97(23):873-9.
8
[Value of carcinoembryonic antigen determinations in the evaluation and surveillance of breast cancers].
Bull Cancer. 1976 Oct-Dec;63(4):595-606.
9
Tumour markers in breast cancer.乳腺癌中的肿瘤标志物
Br Med J. 1979 Apr 21;1(6170):1036.
10
[Tumor markers in breast cancer].[乳腺癌中的肿瘤标志物]
Sov Med. 1985(3):25-9.
引用本文的文献
1
Hemopexin as biomarkers for analyzing the biological responses associated with exposure to silica nanoparticles.血红素结合蛋白作为分析与暴露于二氧化硅纳米颗粒相关的生物反应的生物标志物。
Nanoscale Res Lett. 2012 Oct 8;7(1):555. doi: 10.1186/1556-276X-7-555.
2
Carcinoma of the breast in the Section of Radiology.放射科的乳腺癌
J R Soc Med. 1980 Oct;73(10):734-8. doi: 10.1177/014107688007301010.
3
The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.循环肿瘤相关抗原癌胚抗原（CEA）和糖类抗原19-9（CA 19-9）在胃肠道恶性肿瘤患者的初诊及随访中的临床有效性。
Klin Wochenschr. 1985 Feb 4;63(3):106-15. doi: 10.1007/BF01734248.
本文引用的文献
1
Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy.未经治疗的乳腺癌的自然史（1805 - 1933年）。根据恶性组织学分级对未经治疗和经治疗的病例进行比较。
Br Med J. 1962 Jul 28;2(5299):213-21. doi: 10.1136/bmj.2.5299.213.
2
Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.单核细胞性和单核粒细胞性白血病中的血清及尿液溶菌酶（胞壁质酶）
J Exp Med. 1966 Nov 1;124(5):921-52. doi: 10.1084/jem.124.5.921.
3
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma.血浆癌胚抗原在胃肠道、乳腺癌和支气管癌诊断中的作用。
Br Med J. 1972 Sep 9;3(5827):605-9. doi: 10.1136/bmj.3.5827.605.
4
A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone.一种在人促黄体生成素存在的情况下特异性测量人绒毛膜促性腺激素的放射免疫分析方法。
Am J Obstet Gynecol. 1972 Jul 15;113(6):751-8. doi: 10.1016/0002-9378(72)90553-4.
5
An immunoassay for a pregnancy-associated alpha-macroglobulin using antibody-enzyme conjugates.一种使用抗体 - 酶偶联物检测妊娠相关α-巨球蛋白的免疫测定法。
FEBS Lett. 1974 Oct 1;47(1):190-2. doi: 10.1016/0014-5793(74)80456-4.
6
A simplified procedure for the measurement of total hydroxyproline in urine.
Clin Chim Acta. 1974 Dec 17;57(3):217-23. doi: 10.1016/0009-8981(74)90400-8.
7
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours.非甲状腺肿瘤患者血浆免疫反应性降钙素
Lancet. 1974 Jun 1;1(7866):1080-3. doi: 10.1016/s0140-6736(74)90557-1.
8
Serum alpha-1-acid glycoprotein as an index of dissemination in breast cancer.血清α-1-酸性糖蛋白作为乳腺癌播散的指标。
Br J Surg. 1975 Oct;62(10):816-9. doi: 10.1002/bjs.1800621017.
9
Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer.
J Natl Cancer Inst. 1975 Oct;55(4):791-5. doi: 10.1093/jnci/55.4.791.
10
Elevated plasma sialyltransferase in the cancer patient.癌症患者血浆唾液酸转移酶升高。
Cancer Res. 1975 Mar;35(3):670-2.
Zotero 插件